ANOVA PANCAN result package
Francesco Iorio, EMBL - European Bioinformatics Institute
result parsing started on 2016-03-31 19:01:06 iorio@ebi.ac.uk
Drug Domain: GDSC1000_paper_set, Analysis Domain: panCancer
Individual drug analysis: 261
Drug details and screening numbers
Drug Name: TL-1-85
Drug ID: 261
Synonyms:
Brand name:
Target: MAP3K7 (TAK1)
Number of cell lines screened: 922
Screening concentration range(s): 0.04 to 10.24 uM
Statistically significant associations identified = 2
association id |
FEATURE |
Drug id |
Propr |
Public |
Drug Name |
Drug Target |
N FEATURE pos |
N FEATURE neg |
log max Conc tested |
FEATURE neg logIC50 MEAN |
FEATURE pos logIC50 MEAN |
FEATURE deltaMEAN IC50 |
FEATURE IC50 effectSize |
FEATURE neg Glass delta |
FEATURE pos Glass delta |
ANOVA FEATURE pval |
Tissue ANOVA pval |
MSI ANOVA pval |
ANOVA FEATURE FDR % |
a9 |
BCR-ABL_mut |
261 |
1 |
1 |
TL-1-85 |
MAP3K7 (TAK1) |
5 |
914 |
2.33 |
3.21 |
-4 |
-7.21 |
4.6 ** |
4.6 ** |
7.2 ** |
1.44e-14 |
1.46e-78 |
5.64e-01 |
2.6e-08 |
a90 |
NRAS_mut |
261 |
1 |
1 |
TL-1-85 |
MAP3K7 (TAK1) |
58 |
861 |
2.33 |
3.18 |
3.03 |
-0.153 |
0.093 |
0.092 |
0.11 |
7.33e-06 |
2.09e-75 |
5.72e-01 |
1.3 |
All-tests volcano plot